Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis

Annals of Neurology

Volumn 41, Issue 3, 1997, Pages 326-333

  Rieckmann, Peter ^a,b   Altenhofen, Bernd ^a   Riegel, Antje ^a   Baudewig, Jürgen ^a   Felgenhauer, Klaus ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GADOLINIUM PENTETATE; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS ENCEPHALITIS;

ADULT; BRAIN; CELL ADHESION MOLECULES; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES;

EID: 0031056637     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410307     Document Type: Article

References (49)

1. Larsson HBW, Stubgaard M, Frederiksen JL, et al. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131
2. Katz D, Taubenberger JK, Cannella B, et al Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34: 661-669
3. Kermode AG, Thompson AJ, Tofts PS. Breakdown of the blood brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain 1990;113:1477-1489
4. Koopmans RA, Li DKB, Oger JJF, et al. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39:959-963
5. Goldstein GW. Endothelial cell-astrocyte interactions. A cellular model of the blood-brain barrier. Ann NY Acad Sci 1988; 529:31-39
6. Joo F. The cerebral microvessels in culture, an update. J Neurochem 1992;58:1-17
7. Olsson T. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J Neuroimmunol 1992;40:211-218
8. Hartung HP. Immune-mediated demyelination. Ann Neurol 1993;33:563-567
9. Cross H. Immune cell traffic control and the central nervous system. Semin Neurosci 1992;4:213-219
10. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37:424-435
11. Newcombe J, Hawkins CP, Henderson CL, et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 1991;114:1013-1023
12. Olsson T. Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur J Neurol 1994;1: 7-19
13. Rieckmann P, Michel U, Albrecht M, et al. Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neurosci Lett 1995;186:61-64
14. Sharief MK, Noori MA, Ciardi M, et al. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol 1993;43:15-21
15. Rieckmann P, Nunke K, Burchhardt M, et al. Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J Neuroimmunol 1993;47:133-140
16. Jander S, Heidenreich F, Stoll G. Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology 1993;43:1809-1813
17. Tsukuda N, Miyagi K, Matsuda M, Yanagisawa N. Increased levels of intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy. Ann Neurol 1993;33:646-649
18. Rieckmann P, Martin S, Albrecht M, et al. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 1994;44:2367-2372
19. Matsuda M, Tsukada N, Miyagi K, Yanagisawa N. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-I-associated myelopathy. J Neuroimmunol 1995;59:35-40
20. Dore DP, Newman W, Balabanov R, et al. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 1995;37:55-62
21. Hartung HP, Reiners K, Archelos JJ, et al. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 1995;38:186-193
22. Giovannoni G, Lai M, Thorpe J, et al. Intercellular adhesion molecule-1 correlates with gadolinium enhancement on serial magnetic resonance imaging in multiple sclerosis. Neurology 1996;46(suppl):A367
23. Trojano M, Avolio C, Manzari C, et al. Serum and cerebrospinal fluid-soluble ICAM-1 levels in clinically active, relapsing-remitting multiple sclerosis: differences according to the presence or absence of MR1 gadolinium enhancement. Neurology 1996;46(suppl):A189
24. Felgenhauer K. The filtration concept of the blood-CSF-barrier as basis for the differentiation of CSF proteins. In: Greenwood J, Begley DJ, Sega J M, Lightman S, eds. New concepts of a blood-brain-barrier. London: Plenum, 1995;209-217
25. Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
26. Fuchs M, Kullmann WH, Dössel O. Functional imaging of neuronal brain activities: overlay of distributed neuromagnetic current density images and morphological MR images. Eur Radiol 1993;3:41-48
27. Fillipi M, Horsfield MA, Campi A, et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38: 749-754
28. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987;163:319-328
29. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-937
30. Bastianello S, Pozzilli C, Bernardi S, et al. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 1990;40:591-595
31. Miller DH, Thompson AJ, Morrissey SP, et al. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. J Neurol Neurosurg Psychiatry 1992;55:450-458
32. Katz J, Taubenberger J, Raine CS, et al. Gadolinium enhancing lesions on magnetic resonance imaging: neuropathological findings. Ann Neurol 1990;28:243-248
33. Hawkins CP, Munro PMG, MacKenzie F, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990;113:365-378
34. Thompson A, Miller D, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing-remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-63
35. Tas MW, Barkhof F, van Walderveen MAAA. The effect of gadolinium on the sensitivity and specificity of MR imaging in the initial diagnosis of multiple sclerosis. AJNR 1995;16:259-264
36. Stone LA, Frank JA, Albert PS, et al. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 1995;37:611-619
37. Sobel RA, Mitchell ME, Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990;136:1309-1316
38. Washington R, Burton J, Todd R, et al. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Neurology 1994;35:89-97
39. Svenningsson A, Hansson GK, Andersen O, et al. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol 1993; 34:155-161
40. Thompson EJ. The CSF proteins: a biochemical approach. New York: Elsevier Science, 1988
41. Rieckmann P, Martin S, Albrecht M, Michel U. Soluble adhesion molecules in MS: indicator for relapse and new therapeutic perspectives. In: Proceedings of the 10th ECTRIMS Congress. Athens: Milonas, 1994:70-71 (Abstract)
42. Zoukos Y, Kidd D, Woodroofe MN, et al. Increased expression of high affinity IL-2 receptor and b-adrenoceptors on peripheral mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain 1994;117:307-315
43. Barkhof F, Frequin STFM, Hommes OR, et al. A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolon. Neurology 1992;42:63-67
44. Jacobi C, Reiber H, Flgenhauer K. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid. J Neurol 1986;233:358-365
45. Zerr I, Bodemer M, Räcker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609-1610
46. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-army coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637
47. Kidd D, Thorpe JW, Kendall BE, et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:15-19
48. Revesz T, Kidd D, Thompson AJ, et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994;117:759-765
49. Raine CS. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994;36 (suppl):S61-S72